07/15/2014 - 10:33am

A new survey of Americans ages 34 years and older released Tuesday found that 67% frequently experience joint stiffness and other concerns. 

07/15/2014 - 10:20am

The 2014 United States of Aging Survey released Tuesday found that Americans aged 60 years and older report they are more motivated than the past two years to improve their health by exercising regularly and setting health goals — two simple steps which also relate to reported increases in optimism among seniors.

07/15/2014 - 9:56am

Former Republican Speaker of the House J. Dennis Hastert last week wrote an editorial for the Washington Times supporting the use of such tamper-resistant pseudoephedrine products as Acura Pharmaceuticals' Nexafed and Westport Pharmaceuticals' Zephrex-D.

07/15/2014 - 9:28am

CVS Caremark announced a $1.5 million commitment to the "Technology Solutions for Smarter Health" grant program.

07/14/2014 - 2:08pm

Upsher-Smith Labs on Monday announced the launch of topiramate extended-release capsules, an authorized generic version of Qudexy XR (topiramate) extended-release capsules.

07/14/2014 - 12:45pm

Sandoz on Monday announced the introduction of tobramycin inhalation solution, USP into the U.S. market. The drug is an authorized generic version of Tobi from Novartis.

07/14/2014 - 12:13pm

At the close of the Affordable Care Act’s first open enrollment period, an estimated 9.5 million fewer U.S. adults were uninsured, according to a new Commonwealth Fund survey released last week.

07/14/2014 - 12:02pm

Although the pace of approvals for new orphan drugs — medicines that treat relatively rare conditions — have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs, a newly completed study released last week by the Tufts Center for the Study of Drug Development at Tufts University has concluded.

07/14/2014 - 11:51am

Teva Pharmaceuticals on Monday announced that the Food and Drug Administration has accepted the company's new drug application for albuterol multi-dose dry-powder inhaler, a breath-actuated dry-powder inhaler for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease.